The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells.
Jesridonin, a small molecule obtained through the structural modification of Oridonin, has extensive antitumor activity. In this study, we evaluated both its in vitro activity in the cancer cell line EC109 and its in vivo effect on tumor xenografts in nude mice. Apoptosis induced by Jesridonin was d...
| Main Authors: | Cong Wang, Liping Jiang, Saiqi Wang, Hongge Shi, Junwei Wang, Ran Wang, Yongmei Li, Yinhui Dou, Ying Liu, Guiqin Hou, Yu Ke, Hongmin Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4477902?pdf=render |
Similar Items
-
Aspirin Exerts Its Antitumor Effect in Esophageal Squamous Cell Carcinoma by Downregulating the Expression of ATAD2 and KIF4A
by: Man Zhang, et al.
Published: (2022-01-01) -
Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma
by: Yiqiu Li, et al.
Published: (2023-09-01) -
Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
by: Guiqin Hou, et al.
Published: (2014-01-01) -
Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma
by: Zhaoming Lu, et al.
Published: (2016-01-01) -
Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
by: Guiqin Xie, et al.
Published: (2022-03-01)